Ftse Mib
37.058,18
-0,17%
DAX
21.928,88
0,07%
S&P 500
6.083,57
0,36%
NASDAQ
19.791,99
0,51%
Bitcoin
97.730,13
1,20%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ MoonLake Immunotherapeutics (MLTX) MoonLake Immunotherapeutics (MLTX) Notizie

MoonLake Immunotherapeutics

MLTX
47,11
0,00 (0,00%)
Pre Mercato
Ultimo aggiornamento: 10:00:05
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
23/1/202503:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202513:00GLOBEMoonLake initiates three new clinical trials and further..
18/12/202422:30EDGAR2Form 8-K - Current report
13/11/202414:00GLOBEMoonLake Immunotherapeutics starts Phase 3 IZAR program of..
07/11/202413:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202413:03EDGAR2Form 8-K - Current report
07/11/202413:00GLOBEMoonLake Immunotherapeutics Reports Third Quarter 2024..
08/10/202422:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/9/202413:30EDGAR2Form 8-K - Current report
09/9/202413:00GLOBEMoonLake Immunotherapeutics to host a Capital Markets Update..
07/8/202414:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/8/202414:02EDGAR2Form 8-K - Current report
07/8/202414:00GLOBEMoonLake Immunotherapeutics Reports Second Quarter 2024..
10/6/202422:40EDGAR2Form 8-K - Current report
10/6/202414:00GLOBEMoonLake Immunotherapeutics Announces Positive Regulatory..
07/6/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/6/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/6/202422:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/6/202422:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202413:30EDGAR2Form 8-K - Current report
16/5/202414:00GLOBEMoonLake Immunotherapeutics starts Phase 3 VELA program of..
07/5/202414:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/5/202414:01EDGAR2Form 8-K - Current report
07/5/202414:00GLOBEMoonLake Immunotherapeutics Reports First Quarter 2024..
07/5/202413:57EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
10/4/202413:00BWMoonLake Immunotherapeutics Inks Three-Year Technology..
11/3/202413:01EDGAR2Form 8-K - Current report
10/3/202417:00GLOBEMoonLake announces significant improvements with Nanobody®..
04/3/202414:00GLOBEMoonLake Immunotherapeutics to present MIRA trial data of..
01/3/202401:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202401:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202414:05EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
29/2/202414:03EDGAR2Form 8-K - Current report
29/2/202414:00GLOBEMoonLake Immunotherapeutics Reports Full Year 2023 Financial..
26/2/202415:00EDGAR2Form 8-K - Current report
26/2/202414:00GLOBEMoonLake Immunotherapeutics Announces Positive Feedback from..
23/2/202422:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202400:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202400:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/2/202400:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202422:02EDGAR2Form 144 - Report of proposed sale of securities
15/2/202414:00EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202422:05EDGAR2Form 144 - Report of proposed sale of securities
Apertura: Min: Max:
Chiusura: 47,11

La tua Cronologia

NASDAQ
MLTX
MoonLake Immunotherapeut...
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci